ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Celgene executives whipped up new, lucrative severance plans ahead of Bristol-Myers megadeal
January 08, 2019It’s not only Celgene investors who are set for a big payoff with this week’s $74 billion sale to Bristol-Myers Squibb. Thanks to brand-new severance agreements inked days ahead of the deal announcement, its top executives could reap hefty gains, too.
Pharma Sources Insight January 2025
